tiprankstipranks
Calithera Bio (CALA)
OTHER OTC:CALA
US Market

Calithera Bio (CALA) Stock Price & Analysis

448 Followers

CALA Stock Chart & Stats

Day’s Range$0.03 - $0.03
52-Week Range― - ―
Previous Close$0.03
Volume3.55K
Average Volume (3M)N/A
Market Cap
$97.45K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

CALA FAQ

What was Calithera Bio’s price range in the past 12 months?
Currently, no data Available
What is Calithera Bio’s market cap?
Currently, no data Available
When is Calithera Bio’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Calithera Bio’s earnings last quarter?
Currently, no data Available
Is Calithera Bio overvalued?
According to Wall Street analysts Calithera Bio’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Calithera Bio pay dividends?
    Calithera Bio does not currently pay dividends.
    What is Calithera Bio’s EPS estimate?
    Calithera Bio’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Calithera Bio have?
    Currently, no data Available
    What happened to Calithera Bio’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Calithera Bio?
    Among the largest hedge funds holding Calithera Bio’s share is PRIMECAP Management Co. It holds Calithera Bio’s shares valued at N/A.
      ---

      Calithera Bio Stock Smart Score

      Company Description

      Calithera Bio

      Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Marinus
      Cytokinetics
      Crispr Therapeutics AG
      Adverum Biotechnologies
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis